Search

everythinglearnresearchcommunity

for

Search:↓

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Higher dihydrotestosterone (DHT) levels are linked to male pattern baldness.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Platelet-rich plasma may help with hair loss by promoting hair growth.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

Targeting the PIEZO1 and MLCK axis may offer a new treatment for hair loss.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Eclipta alba flavonoids may help treat diabetes by effectively inhibiting Aldose reductase.

Non-immune factors play a significant role in alopecia areata.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

Activated protein C helps protect mice from long-term radiation damage.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.